BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38187174)

  • 1. S-1 as an alternative treatment after 5-fluorouracil-induced coronary vasospasm in a patient with small bowel adenocarcinoma: a case report.
    Mitome N; Machida N; Shichiri Y; Kuwashima H; Murai A; Maeda S
    Int Cancer Conf J; 2024 Jan; 13(1):40-44. PubMed ID: 38187174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
    Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
    Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute coronary syndrome associated with continuous 5-Fluorouracil infusion in a patient with metastatic colorectal cancer-a case report with a discussion on this clinical dilemma.
    Paiva CE; Paiva BS; Garita R; Michelin OC; Okoshi K
    J Gastrointest Cancer; 2009; 40(3-4):133-7. PubMed ID: 19936641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil Rechallenge After Cardiotoxicity.
    Desai A; Mohammed T; Patel KN; Almnajam M; Kim AS
    Am J Case Rep; 2020 Aug; 21():e924446. PubMed ID: 32860674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen.
    Cerny J; Hassan A; Smith C; Piperdi B
    Clin Colorectal Cancer; 2009 Jan; 8(1):55-8. PubMed ID: 19203898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
    Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
    Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe administration of S-1 after 5-fluorouracil-induced cardiotoxicity in a patient with colorectal cancer.
    Franck C; Malfertheiner P; Venerito M
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
    Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
    J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion.
    Redman JM; Rhea LP; Brofferio A; Whelpley M; Gulley JL; Gatti-Mays ME; McMahon S; Cordes LM; Strauss J
    J Gastrointest Oncol; 2019 Oct; 10(5):1010-1014. PubMed ID: 31602339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-fluorouracil-induced coronary vasospasm.
    Shoemaker LK; Arora U; Rocha Lima CM
    Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative Chemotherapy: Does It Only Provide False Hope? The Role of Palliative Care in a Young Patient With Newly Diagnosed Metastatic Adenocarcinoma.
    Doverspike L; Kurtz S; Selvaggi K
    J Adv Pract Oncol; 2017; 8(4):382-386. PubMed ID: 30018843
    [No Abstract]   [Full Text] [Related]  

  • 13. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
    Ray JC; Cho P; Dragon M; Graham CG
    J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.
    Zafar A; Drobni ZD; Lei M; Gongora CA; Quinaglia T; Lou UY; Mosarla R; Murphy SP; Jones-O'Connor M; Mahmood A; Hartmann S; Gilman HK; Weekes CD; Nipp R; Clark JR; Clark JW; Blaszkowsky LS; Tavares E; Neilan TG
    PLoS One; 2022; 17(4):e0265767. PubMed ID: 35390017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
    Osterlund P; Kinos S; Pfeiffer P; Salminen T; Kwakman JJM; Frödin JE; Shah CH; Sorbye H; Ristamäki R; Halonen P; Soveri LM; Heervä E; Ålgars A; Bärlund M; Hagman H; McDermott R; O'Reilly M; Röckert R; Liposits G; Kallio R; Flygare P; Teske AJ; van Werkhoven E; Punt CJA; Glimelius B
    ESMO Open; 2022 Jun; 7(3):100427. PubMed ID: 35798468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.
    Fabin N; Bergami M; Cenko E; Bugiardini R; Manfrini O
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
    Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
    Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Iatrogenic acute coronary syndrome"--59 year old patient with adenocarcinoma of ascending colon and stenocardia while receiving adjuvant chemotherapy with 5-fluorouracil].
    Gundling F; Fuchs M; Nowak L; Antoni D; Hoffmann E; Schepp W
    Z Gastroenterol; 2006 Sep; 44(9):975-9. PubMed ID: 16981070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in
    Modest DP; Karthaus M; Fruehauf S; Graeven U; Müller L; König AO; Fischer von Weikersthal L; Caca K; Kretzschmar A; Goekkurt E; Haas S; Kurreck A; Stahler A; Held S; Jarosch A; Horst D; Reinacher-Schick A; Kasper S; Heinemann V; Stintzing S; Trarbach T
    J Clin Oncol; 2022 Jan; 40(1):72-82. PubMed ID: 34533973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.
    Fata F; Ron IG; Kemeny N; O'Reilly E; Klimstra D; Kelsen DP
    Cancer; 1999 Oct; 86(7):1129-34. PubMed ID: 10506695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.